Verrica Pharmaceuticals Inc (VRCA):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Verrica Pharmaceuticals Inc (VRCA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8161
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Verrica Pharmaceuticals Inc (Verrica) is a clinical-stage medical dermatology company that discovers, develops and commercializes therapeutics for the treatment of skin diseases. The company’s lead product candidate, VP-102, is in two phase 3 clinical trials for the treatment of molluscum contagiosum, a high contagious and primarily pediatric viral skin disease; and in a Phase 2 clinical trial for the treatment of common warts. Verrica is headquartered in West Chester, Pennsylvania, the US.

Verrica Pharmaceuticals Inc (VRCA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Verrica Pharma Raises USD20 Million in Venture Financing 10
Verrica Pharma Raises USD5 Million in Venture Financing 11
Verrica Pharma Raises USD2.4 Million in Financing Round 12
Equity Offering 13
Verrica Pharma Raises USD86.3 Million in IPO of Shares 13
Verrica Pharmaceuticals Inc – Key Competitors 14
Verrica Pharmaceuticals Inc – Key Employees 15
Verrica Pharmaceuticals Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Financial Announcements 17
Aug 07, 2018: Verrica reports second quarter 2018 financial results 17
Corporate Communications 18
Sep 24, 2018: Verrica Pharmaceuticals announces inclusion in Russell 2000 and Russell 3000 indexes 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Verrica Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Verrica Pharma Raises USD20 Million in Venture Financing 10
Verrica Pharma Raises USD5 Million in Venture Financing 11
Verrica Pharma Raises USD2.4 Million in Financing Round 12
Verrica Pharma Raises USD86.3 Million in IPO of Shares 13
Verrica Pharmaceuticals Inc, Key Competitors 14
Verrica Pharmaceuticals Inc, Key Employees 15

List of Figures
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Verrica Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Verrica Pharmaceuticals Inc (VRCA):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BrightPath Early Learning Inc.:企業の戦略的SWOT分析
    BrightPath Early Learning Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Knight-Swift Transportation Holdings Inc. (KNX):企業の財務・戦略的SWOT分析
    Knight-Swift Transportation Holdings Inc. (KNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • XTL Biopharmaceuticals Ltd (XTLB):企業の財務・戦略的SWOT分析
    Summary XTL Biopharmaceuticals Ltd (XTL) is a drug development company that focuses on the acquisition and development of late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. The company’s pipeline products include hCDR1 peptide and recombinant human erythropoietin …
  • Yeda Research and Development Company Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Yeda Research and Development Company Ltd (Yeda), a subsidiary of Weizmann Institute of Science is a technology transfer company that provides research and science education. The company identifies and assesses research projects with commercial potential, protects the intellectual property o …
  • Oriental Bank of Commerce:企業の戦略・SWOT・財務分析
    Oriental Bank of Commerce - Strategy, SWOT and Corporate Finance Report Summary Oriental Bank of Commerce - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Safety-Kleen Inc:企業の戦略的SWOT分析
    Safety-Kleen Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Aquila Resources Ltd:企業の戦略・SWOT・財務分析
    Aquila Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Aquila Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • United Networks Ltd (UNL):企業の財務・戦略的SWOT分析
    United Networks Ltd (UNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Ashghal:企業の戦略・SWOT・財務情報
    Ashghal - Strategy, SWOT and Corporate Finance Report Summary Ashghal - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Sangam (India) Ltd.:企業の戦略・SWOT・財務分析
    Sangam (India) Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sangam (India) Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Tenneco Inc (TEN):企業の財務・戦略的SWOT分析
    Tenneco Inc (TEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Isuzu Motors Limited:企業の戦略・SWOT・財務情報
    Isuzu Motors Limited - Strategy, SWOT and Corporate Finance Report Summary Isuzu Motors Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Numaligarh Refinery Ltd:企業の戦略的SWOT分析
    Numaligarh Refinery Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Varex Imaging Corp (VREX):企業の財務・戦略的SWOT分析
    Varex Imaging Corp (VREX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Valmieras Stikla Skiedra AS:企業の戦略・SWOT・財務情報
    Valmieras Stikla Skiedra AS - Strategy, SWOT and Corporate Finance Report Summary Valmieras Stikla Skiedra AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • ARC Resources Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    ARC Resources Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary ARC Resources Ltd (ARC) is an energy company, which carries out exploration, development and production of conventional crude oil and natural gas reserves. Its produces light and medium crude oil, …
  • Pfizer Inc.:戦略・SWOT・企業財務分析
    Pfizer Inc. - Strategy, SWOT and Corporate Finance Report Summary Pfizer Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Venture Corporation Limited:企業の戦略・SWOT・財務情報
    Venture Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Venture Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Cellnet Group Ltd (CLT):企業の財務・戦略的SWOT分析
    Cellnet Group Ltd (CLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Zetro Aerospace Corporation Sdn. Bhd.:企業の戦略・SWOT・財務情報
    Zetro Aerospace Corporation Sdn. Bhd. - Strategy, SWOT and Corporate Finance Report Summary Zetro Aerospace Corporation Sdn. Bhd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆